Funding: This work was supported by the Alliance for Cancer Gene Therapy (R.H.V.), the Onyx and Breezy Foundation (K.U.S.), the Barry and Savannah Poodle Memorial Fund and the Mari Lowe Comparative Oncology Center (N.J.M.),
the Immunobiology Program of the Abramson Cancer Center at the University of Pennsylvania (NIH grant P30 CA016520, R.H.V.), and the Oncology Research fund at the Veterinary Hospital of the University of Pennsylvania (K.U.S.).
Not exact matches
Today, the Sterling Professor of
Immunobiology, and HHMI investigator, directs one of the top immunology
programs in the country, as well as his own lab.
Program in Cellular and Molecular Medicine, Boston Children's Hospital, Department of Microbiology and
Immunobiology, Harvard Medical School, Boston, Massachusetts, USA.
Dr. Lieping Chen currently serves as the United Technologies Corporation Professor in Cancer Research, Professor of
Immunobiology, Dermatology and Medical Oncology at Yale School of Medicine and co-Director of the Cancer Immunology
Program of Yale Cancer Center in New Haven, CT..